证券记录 · 已归档季度
TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
16被追踪持有人
+5Δ持有人
65.80M持有股份
$152.01M报告持仓市值
+5新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 +21.7% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.83M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | — | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | — |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | — |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | — | 5.37M | $12.04M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (被动) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 7.32M | +60.1% | $16.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (被动) | 5.14M | +58.9% | $11.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 4.84M | 新增 | $11.18M | 0.0% | New | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 3.79M | +3.5% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Geode Capital Management ✦ (被动) | 3.79M | +3.5% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Millennium Management ✦ | 2.94M | +65.6% | $6.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 528.99K | +144.2% | $1.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 401.51K | 新增 | $927,486 | 0.0% | New | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 84.60K | +14.3% | $196,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Marshall Wace ✦ | 79.50K | 新增 | $183,640 | 0.0% | New | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 79.50K | 新增 | $183,640 | 0.0% | New | 1 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 54.90K | 新增 | $126,819 | 0.0% | New | 1 | SEC ↗ |
| 34 | Two Sigma Investments ✦ | 32.68K | 新增 | $75,495 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $11.18M | 0.0% |
| D. E. Shaw & Co. | $927,486 | 0.0% |
| Marshall Wace | $183,640 | 0.0% |
| Marshall Wace | $183,640 | 0.0% |
| Renaissance Technologies | $126,819 | 0.0% |
| Two Sigma Investments | $75,495 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 190 持有人, 265.00M 股份, $1.21B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据